Professional Documents
Culture Documents
Blood disorders
Anemia
Nutritional anemia
Hemolytic anemia
Aplastic anemia
Sickle cell anemia
ANEMIA
Acondition in which
the hemoglobin
concentration is
lower than normal
ANEMIA
Three broad categories
1. Loss of RBC- occurs with
bleeding
2. Decreased RBC production
3. Increased RBC destruction
Hypoproliferative Anemia
Nursing Management
2. Administer iron
Oral preparations tablets- Fe
fumarate, sulfate and gluconate
Advise to take iron ONE hour before
meals
Take it with vitamin C
Continue taking it for several months
Hypoproliferative Anemia
Nursing Management
2. Administer iron
Oral preparations- liquid
It stains teeth
Drink it with a straw
Stool may turn blackish- dark in
color
Advise to eat high-fiber diet to
counteract constipation
Hypoproliferative Anemia
Nursing Management
2. Administer iron
IM preparation
Administer DEEP IM using the Z-
track method
Avoid vigorous rubbing
Can cause local pain and staining
APLASTIC ANEMIA
Acondition
characterized by
decreased number of
RBC as well as WBC
and platelets
APLASTIC ANEMIA
CAUSATIVE FACTORS
1. Environmental toxins-
pesticides, benzene
2. Certain drugs-
Chemotherapeutic agents,
chloramphenicol,
phenothiazines, Sulfonamides
3. Heavy metals
4. Radiation
APLASTIC ANEMIA
Pathophysiology
Toxins cause a direct bone
marrow depression acellualr
bone marrow decreased
production of blood elements
APLASTIC ANEMIA
ASSESSMENT FINDINGS
1. fatigue
2. pallor
3. dyspnea
4. bruising
5. splenomegaly
6. retinal hemorrhages
APLASTIC ANEMIA
LABORATORY FINDINGS
1. CBC- decreased blood cell
numbers
2. Bone marrow aspiration
confirms the anemia-
hypoplastic or acellular
marrow replaced by fats
APLASTIC ANEMIA
Medical Management
1. Bone marrow
transplantation
2. Immunosupressant
drugs
3. Rarely, steroids
4. Blood transfusion
APLASTIC ANEMIA
Nursing management
1. Assess for signs of
bleeding and infection
2. Instruct to avoid
exposure to offending
agents
Megaloblastic Anemias
Anemias characterized by
abnormally large RBC
secondary to impaired
DNA synthesis due to
deficiency of Folic acid
and/or vitamin B12
Megaloblastic Anemias
Folic Acid deficiency
Causative factors
1. Alcoholism
2. Mal-absorption
3. Diet deficient in
uncooked vegetables
Megaloblastic Anemias
Pathophysiology of Folic acid
deficiency
Decreased folic acid impaired
DNA synthesis in the bone
marrow impaired RBC
development, impaired nuclear
maturation but CYTOplasmic
maturation continues large size
Megaloblastic Anemias
Vitamin B12 deficiency
Causative factors
1. Strict vegetarian diet
2. Gastrointestinal malabsorption
3. Crohn's disease
4. gastrectomy
Megaloblastic Anemias
Vitamin B12 deficiency
Pernicious Anemia
Due to the absence of intrinsic
factor secreted by the parietal cells
Intrinsic factor binds with Vit. B12
to promote absorption
Megaloblastic Anemias
Assessment findings
1. weakness
2. fatigue
3. listless
4. neurologic manifestations are
present only in Vit. B12
deficiency
Megaloblastic Anemias
Assessment findings
Pernicious Anemia
– Beefy, red, swollen tongue
– Mild diarrhea
– Extreme pallor
– Paresthesias in the extremities
Megaloblastic Anemias
Laboratory findings
1. Peripheral blood smear- shows
giant RBCs, WBCs with giant
hypersegmented nuclei
2. Very high MCV
3. Schilling’s test
4. Intrinsic factor antibody test
Megaloblastic Anemias
Medical Management
1. Vitamin supplementation
– Folic acid 1 mg daily
2. Diet supplementation
– Vegetarians should have vitamin
intake
3.Lifetime monthly injection of IM
Vit B12
Megaloblastic Anemias
Nursing Management
1. Monitor patient
2. Provide assistance in
ambulation
3. Oral care for tongue sore
4. Explain the need for lifetime
IM injection of vit B12
Hemolytic Anemia: Sickle Cell
Asevere chronic
incurable hemolytic
anemia that results
from heritance of the
sickle hemoglobin gene.
Hemolytic Anemia: Sickle Cell
Causative factor
–Genetic inheritance of
the sickle gene- HbS
gene
Hemolytic Anemia: Sickle Cell
Pathophysiology
Decreased O2, Cold,
Vasoconstriction can
precipitate sickling
process
Hemolytic Anemia: Sickle Cell
Pathophysiology
Factors cause defective
hemoglobin to acquire a
rigid, crystal-like C-shaped
configuration Sickled RBCs
will adhere to endothelium
pile up and plug the vessels
ischemia results pain,
swelling and fever
Hemolytic Anemia: Sickle Cell
Assessment Findings
1. jaundice
2. enlarged skull and
facial bones
3. tachycardia, murmurs
and cardiomegaly
Hemolytic Anemia: Sickle Cell
Assessment Findings
Primary sites of
thrombotic occlusion:
spleen, lungs and CNS
Chest pain, dyspnea
Hemolytic Anemia: Sickle Cell
Assessment Findings
1. Sickle cell crises
– Results from tissue hypoxia
and necrosis
2. Acute chest syndrome
– Manifested by a rapidly falling
hemoglobin level, tachycardia,
fever and chest infiltrates in
the CXR
Hemolytic Anemia: Sickle Cell
Medical Management
1. Bone marrow transplant
2. Hydroxyurea
–Increases the HbF
3. Long term RBC
trnasfusion
Hemolytic Anemia: Sickle Cell
Nursing Management
1. manage the pain
–Support and elevate
acutely inflamed joint
–Relaxation techniques
–analgesics
Hemolytic Anemia: Sickle Cell
Nursing Management
2. Prevent and manage
infection
–Monitor status of patient
–Initiate prompt antibiotic
therapy
Hemolytic Anemia: Sickle Cell
Nursing Management
3. Promote coping skills
–Provide accurate information
–Allow patient to verbalize
her concerns about
medication, prognosis and
future pregnancy
Hemolytic Anemia: Sickle Cell
Nursing Management
4. Monitor and prevent
potential complications
–Provide always adequate
hydration
–Avoid cold, temperature that
may cause vasoconstriction
Hemolytic Anemia: Sickle Cell
Nursing Management
4. Monitor and prevent
potential complications
–Leg ulcer
Aseptic technique
Hemolytic Anemia: Sickle Cell
Nursing Management
4. Monitor and prevent
potential complications
–Priapism
Sudden painful erection
Instruct patient to empty
bladder, then take a warm
bath
Polycythemia
Refers to an INCREASE
volume of RBCs
The hematocrit is ELEVATED
to more than 55%
Clasified as Primary or
Secondary
Polycythemia
POLYCYTHEMIA VERA
–Primary Polycythemia
–A proliferative disorder in
which the myeloid stem
cells become uncontrolled
Polycythemia
POLYCYTHEMIA VERA
Causative factor
–unknown
Polycythemia
POLYCYTHEMIA VERA
Pathophysiology
–The stem cells grow
uncontrollably
–The bone marrow becomes
HYPERcellular and all the blood
cells are increased in number
Polycythemia
POLYCYTHEMIA VERA
Pathophysiology
–The spleen resumes its function
of hematopoiesis and enlarges
–Blood becomes thick and viscous
causing sluggish circulation
Polycythemia
POLYCYTHEMIA VERA
Pathophysiology
–Overtime, the bone marrow
becomes fibrotic
Polycythemia
POLYCYTHEMIA VERA
Assessment findings
–1. Skin is ruddy
–2. Splenomegaly
–3. headache
–4. dizziness, blurred vision
–5. Angina, dyspnea and
thrombophlebitis
Polycythemia
POLYCYTHEMIA VERA
Laboratory findings
–1. CBC- shows elevated RBC
mass
–2. Normal oxygen saturation
–3 Elevated WBC and Platelets
Polycythemia
POLYCYTHEMIA VERA
Complications
–1. Increased risk for
thrombophlebitis, CVA and MI
–2. Bleeding due to
dysfunctional blood cells
Polycythemia
POLYCYTHEMIA VERA
Medical Management
–1. To reduce the high blood cell mass-
PHLEBOTOMY
–2. Allopurinol
–3. Dipyridamole
–4. Chemotherapy to suppress bone
marrow
Polycythemia
Nursing Management
– 1. Primary role of the nurse is EDUCATOR
– 2. Regularly asses for the development
of complications
– 3. Assist in weekly phlebotomy
– 4. Advise to avoid alcohol and aspirin
– 5. Advise tepid sponge bath or cool water
to manage pruritus
Leukemia
Malignant disorders of blood
forming cells characterized by
UNCONTROLLED proliferation of
WHITE BLOOD CELLS in the bone
marrow- replacing marrow
elements . The WBC can also
proliferate in the liver, spleen and
lymph nodes.
Leukemia
Theleukemias are named
after the specific lines of
blood cells afffected primarily
– Myeloid
– Lymphoid
– Monocytic
Leukemia
The leukemias are named also
according to the maturation of cells
ACUTE
– The cells are primarily immature
CHRONIC
– The cells are primarily mature or
diferentiated
Leukemia
ACUTE myelocytic leukemia
ACUTE lymphocytic leukemia